RIEMSER Pharma

Greifswald, Germany Founded: 2000 • Age: 26 yrs Acquired By Esteve
Contract development and manufacturing services for pharmaceutical APIs are provided.

About RIEMSER Pharma

RIEMSER Pharma is a Healthcare company based in Greifswald (Germany) founded in 2000, and was acquired by Esteve in January 2020. Contract development and manufacturing services for pharmaceutical APIs are provided. RIEMSER Pharma has completed 2 acquisitions, including Intrapharm Labs and Zaltanpharma. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.

Company details

RIEMSER Pharma was founded in 2000 in Greifswald, Germany, as a provider in the pharmaceutical sector. Contract development and manufacturing services are offered for active pharmaceutical ingredients, including small molecules, high-potency APIs, and advanced intermediates. Research and development, production, and project management are encompassed in the operations. Support is extended to originator companies for innovative product launches, with facilities located in Germany.

  • Headquarters Greifswald, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Website riemser.com
  • Acquired by Esteve (Jan 2020)
Key Metrics

Funding Insights of RIEMSER Pharma

  • Total Rounds 1
  • Investors Count 2

All 1 funding rounds of RIEMSER Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2007Private Equity Round–TVM Capital, GE Healthcare Finance
–
Valuation history

12 investors in total: 12 institutional.

Investors in RIEMSER Pharma

RIEMSER Pharma has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Fosun, Mylan and Stada.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Capital is invested in life science innovations for healthcare transformation.
tvm-capital.comMunich, Germany
nordiccapital.com
Montagu Private Equity is engaged in mid-market business investments.
montagu.comFrankfurt, Germany
Private investment firm specializing in markets and partnerships.
ardian.com
gehealthcarefinance.com
ikinvest.com
Generic and specialty pharmaceuticals are manufactured and marketed globally.
1954mylan.comCanonsburg, United States
Diversified investment, asset management, and insurance services are offered globally.
1992fosun.comShanghai, China
Provider of generics and biosimilars
1895stada.comBad Vilbel, Germany
Integrated pharmaceutical manufacturing and distribution services are provided.
1994sphchina.comShanghai, China
Premium access

Investor details for RIEMSER Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by RIEMSER Pharma

RIEMSER Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Intrapharm Labs and Zaltanpharma.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Diversified drugs are distributed by Zaltanpharma in Spain.
zaltanpharma.comLas Rozas De Madrid, Spain2017Oct 2019β€’β€’β€’β€’
OTC products manufacturer and supplier
intrapharmlabs.comCookham, United Kingdom1999Nov 2015β€’β€’β€’β€’
Premium access

Complete acquisition details for RIEMSER Pharma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of RIEMSER Pharma

7 dated milestones of RIEMSER Pharma across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded RIEMSER Pharma is founded.
  2. Funding First funding round.
  3. Exit Acquired by Ardian.
  4. Acquisition Acquires Intrapharm Labs.
  5. Exit Acquired by Stada.
  6. Acquisition Acquires Zaltanpharma.
  7. Exit Acquired by Esteve.

Web traffic of RIEMSER Pharma

Websites that share an audience with RIEMSER Pharma (riemser.com).

Similar websites

Websites whose visitors overlap most with RIEMSER Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cesra.de
cesra.de
100%
–
eurim.de
eurim.de
95%
#6,966,716–
engelhard.de
92%
10.9K#1,332,804View details
betapharm.de
90%
View details
berco-arzneimittel.de
berco-arzneimittel.de
88%
#11,507,325–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for RIEMSER Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about RIEMSER Pharma

RIEMSER Pharma was founded in 2000 and raised its 1st funding round 7 years after it was founded.

RIEMSER Pharma is headquartered in Greifswald, Germany. It is registered at Greifswald, Mecklenburg-vorpommern, Germany.

RIEMSER Pharma was founded in 2000 in Greifswald, Germany, as a provider in the pharmaceutical sector. Contract development and manufacturing services are offered for active pharmaceutical ingredients, including small molecules, high-potency APIs, and advanced intermediates. Research and development, production, and project management are encompassed in the operations. Support is extended to originator companies for innovative product launches, with facilities located in Germany.

RIEMSER Pharma has made 2 acquisitions, including Intrapharm Labs, and Zaltanpharma.

RIEMSER Pharma has 12 investors. Key investors include Fosun, Mylan, Stada, Shanghai Pharmaceuticals Holding, and Esteve.

Yes. RIEMSER Pharma was acquired by Esteve in January 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available